Suppr超能文献

ESCCAL-1通过与食管鳞状细胞癌中的半乳糖凝集素-1相互作用并使其稳定来促进细胞周期进程。

ESCCAL-1 promotes cell-cycle progression by interacting with and stabilizing galectin-1 in esophageal squamous cell carcinoma.

作者信息

Cui Yuanbo, Yan Ming, Wu Wei, Lv Pengju, Wang Jinwu, Huo Yanping, Lou Yanan, Ma Xiwen, Chang Jing, Guan Fangxia, Cao Wei

机构信息

Translational Medicine Center, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, 450007, China.

School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China.

出版信息

NPJ Precis Oncol. 2022 Mar 1;6(1):12. doi: 10.1038/s41698-022-00255-x.

Abstract

Long non-coding RNAs (LncRNAs) play important roles in the development of human esophageal squamous cell carcinoma (ESCC). Our previous studies have shown that knockdown of LncRNA ESCCAL-1 expression inhibits the growth of ESCC cells, but the mechanisms remain largely unknown. In this study, we show that over-expression of ESCCAL-1 promotes ESCC cell proliferation and cell-cycle progression by blocking ubiquitin-mediated degradation of an oncoprotein galectin-1 (Gal-1). Multiple LncRNA expression datasets as well as our own data together reveal that ESCCAL-1 is evidently up-regulated in ESCC tissues and exhibits promising diagnostic value. Over-expression of ESCCAL-1 augmented ESCC cell proliferation and cell-cycle progression, whereas down-regulation of ESCCAL-1 resulted in the opposite effects. Mechanistically, LncRNA ESCCAL-1 directly binds to Gal-1 and positively regulates its protein level without affecting its mRNA level. Up-regulation of Gal-1 facilitated ESCC cell proliferation and cell-cycle progress. Knockdown of Gal-1 mitigated the effects of ESCCAL-1-mediated high cellular proliferation, NF-κB signaling activation and tumorigenicity of ESCC cells. Thus, our findings provide novel insight into the mechanism by which ESCCAL-1 facilitates ESCC tumorigenesis and cell-cycle progression by interacting with and stabilizing Gal-1 protein, suggesting a potential therapeutic target for ESCC.

摘要

长链非编码RNA(LncRNAs)在人类食管鳞状细胞癌(ESCC)的发展中发挥着重要作用。我们之前的研究表明,敲低LncRNA ESCCAL-1的表达会抑制ESCC细胞的生长,但其机制仍 largely未知。在本研究中,我们表明ESCCAL-1的过表达通过阻断泛素介导的癌蛋白半乳糖凝集素-1(Gal-1)的降解来促进ESCC细胞增殖和细胞周期进程。多个LncRNA表达数据集以及我们自己的数据共同显示,ESCCAL-1在ESCC组织中明显上调,并具有良好的诊断价值。ESCCAL-1的过表达增强了ESCC细胞增殖和细胞周期进程,而ESCCAL-1的下调则产生相反的效果。从机制上讲,LncRNA ESCCAL-1直接与Gal-1结合并正向调节其蛋白水平,而不影响其mRNA水平。Gal-1的上调促进了ESCC细胞增殖和细胞周期进程。敲低Gal-1减轻了ESCCAL-1介导的高细胞增殖、NF-κB信号激活和ESCC细胞致瘤性的影响。因此,我们的发现为ESCCAL-1通过与Gal-1蛋白相互作用并使其稳定来促进ESCC肿瘤发生和细胞周期进程的机制提供了新的见解,提示了ESCC的一个潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f463/8888636/bac661dcea46/41698_2022_255_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验